Phosphatidic Acid Phosphatase Type 2d (PAP2D) Antibody
REQUEST MORE INFO
Catalogue No: abx028719
Price:
US$326.25
(Size: 80 µl)
Orders to United States ship from United States
Add to Cart
Buy It Now
GET A QUOTE
Documents
Datasheet SDS
PAP2D is a type 2 member of the phosphatidic acid phosphatase (PAP) family. All type 2 members of this protein family contain 6 transmembrane regions, and a consensus N-glycosylation site. PAPs convert phosphatidic acid to diacylglycerol, and function in de novo synthesis of glycerolipids as well as in receptor-activated signal transduction mediated by phospholipase D. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq].
Research Articles on Phosphatidic Acid Phosphatase Type 2d (PAP2D)
| Target | Phosphatidic Acid Phosphatase Type 2d (PAP2D) |
| Clonality | Polyclonal |
| Reactivity | Human |
| Tested Applications | ELISA, WB |
| Host | Rabbit |
| Recommended dilutions | WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Immunogen | KLH-conjugated synthetic peptide between 78-106 amino acids from the Central region of human PAP2D. |
| Isotype | IgG |
| Form | Liquid |
| Purification | Purified through a protein A column, followed by peptide affinity purification. |
| Storage | Aliquot and store at 2-8°C for up to 2 weeks, or at -20°C for long term storage. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| UniProt Primary AC | Q32ZL2 (UniProt, ExPASy) |
| UniProt Secondary AC | A8MPX4, B7UCH3, Q32ZD0, Q3ZCU7 |
| UniProt Entry Name | PLPR5_HUMAN |
| KEGG | hsa:163404 |
| String | 9606.ENSP00000263177 |
| Molecular Weight | Calculated MW: 35.4 kDa |
| Buffer | PBS containing 0.09% sodium azide. |
| Specificity | Predicted to react with Mouse PLPPR5. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |

